HPLC determination of bendrofluazide in capsules

Barnes, A.R. and Nash, S. (1993). HPLC determination of bendrofluazide in capsules. International Journal of Pharmaceutics, 94 (1-3), pp. 231-234.

Abstract

A high-performance liquid Chromatographie method for the determination of bendrofluazide in extemporaneously prepared 1.25 mg capsules is described. This employs a hexyl reversed-phase column, maintained at ambient temperature. The method is stability-indicating and the mean within-day recovery of bendrofluazide from the capsules was 100.2% (±3.8%, 95% confidence limits).

Publication DOI: https://doi.org/10.1016/0378-5173(93)90028-E
Divisions: Life & Health Sciences > Pharmacy
Uncontrolled Keywords: assay,bendrofluazide,capsules,HPLC,tablets,Pharmaceutical Science
Published Date: 1993-06-21

Download

Full text not available from this repository.

Export / Share Citation


Statistics

Additional statistics for this record